Dr. Jaeyeon Kim, Indiana University "Pharmacologic Prevention of Ovarian and Breast Cancer in BRCA1 Carriers"
- Event Type
- Seminar/Symposium
- Sponsor
- MIP Seminar Committee
- Location
- Charles Miller Auditorium, B102, CLSL
- Date
- Sep 5, 2024 11:00 am
- Speaker
- Jaeyeon Kim, DVM, Ph.D.
- Contact
- Julie Moore
- jmoor@illinois.edu
- Views
- 203
- Originating Calendar
- Molecular and Integrative Physiology (MIP) Department Seminar Series
Dr. Kim has been an Assistant Professor in the Department of Biochemistry and Molecular Biology at the Indiana University School of Medicine, and also an investigator at Indiana University Simon Cancer Center. Harnessing these mouse models, combined with molecular and genetic approaches, his lab focuses on uncovering the molecular etiology and mechanism of ovarian cancer: how it initiates, progresses, and metastasizes, escalating to an incurable malignancy. Among the prime interests is to define the molecular basis underlying the interactions between genes and hormone in the development, progression, and metastasis of ovarian cancer. His research also aims to understand the role of epigenetic changes in the progression of ovarian cancer. Besides, applying insights from these mouse models, his lab also investigates the molecular mechanism of triple-negative breast cancer. A lucid understanding of the molecular underpinning of ovarian and breast cancer will be crucial to medical advances in the early detection, effective treatment of advanced cancer, and prevention of these malignances.
https://medicine.iu.edu/faculty/23617/kim-jaeyeon